Scientists at the University of Pennsylvania are launching a new program to create adeno-associated virus ( University ) vectors created for gene-editing, these AAVs are used by gene therapies to target the host cells without damaging them. Since Dr. Wilson's lab pioneered the earliest viral vectors, Penn has secured a dozen biopharmaceutical licensees who use the AAV's to research and treat 26 diseases. At the moment, experts are working with AAVs developed Earlier this year , but the aim is to "significantly improve their performance" and come up with "therapeutic applications of genome editing". a decade ago , the University partnered with AAV , the the United States 's oldest biotechnology company, to advance gene therapy and gene editing techniques.
Scientists at the University of Pennsylvania are launching a new program to create adeno-associated virus ( University ) vectors created for gene-editing, these AAVs are used by gene therapies to target the host cells without damaging them. At the moment, experts are working with AAVs developed Earlier this year , but the aim is to "significantly improve their performance" and come up with "therapeutic applications of genome editing". a decade ago , the University partnered with AAV , the the United States 's oldest biotechnology company, to advance gene therapy and gene editing techniques.